Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Medicare Advantage (MA) has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder. | LAS VEGAS—Medicare Advantage has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder.
STAT
OCTOBER 9, 2023
The number of stroke deaths worldwide is set to climb 50% to nearly 10 million by 2050, with most cases occurring in low- and middle-income countries, according to a new wide-ranging report from the World Stroke Organization-Lancet Neurology Commission. The paper also projected that strokes will cause more disability worldwide, estimating that disability-adjusted life-years – the years of life lost and years living with stroke-induced disability – will grow about 30% to reach 190 m
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
OCTOBER 9, 2023
Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.
Fierce Pharma
OCTOBER 9, 2023
Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers. | Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 9, 2023
Use of antidepressants and other classes of prescription drugs can increase the risk of driving impairment compared to nonuse, so clinicians and pharmacists should review these risks with older adults.
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Google's cloud division unveiled new artificial intelligence-powered search capabilities to help doctors and nurses quickly access patients' clinical notes and other medical information a | Google's cloud division unveiled new artificial intelligence-powered search capabilities to help doctors and nurses quickly access patients' clinical notes and other medical information across different data sources.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 9, 2023
Delfi Diagnostics, a well-funded startup in the burgeoning field of creating blood tests to detect cancer, said on Monday that it is launching a new test, FirstLook Lung, to try to identify people who could most benefit from lung cancer screening. The approach represents a new one in the field of liquid biopsy, in which DNA fragments in blood are used to detect or learn about tumors.
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Despite all the digital innovation in healthcare, a visit to the doctor's office often entails filling out forms on a clipboard and repetitive paperwork. | Despite all the digital innovation in healthcare, a visit to the doctor's office often entails filling out forms on a clipboard and repetitive paperwork. Clear, a company well recognized for its biometric identity verification used in airports, wants to fix these pain points.
Pharmacy Times
OCTOBER 9, 2023
Individuals treated with esketamine were more likely to reach remission and remain relapse-free at 8 weeks of treatment.
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS — Highmark Health is joining forces with Spring Health to expand behavioral access for a wide swath of its members. | LAS VEGAS — Highmark Health is joining forces with Spring Health to expand behavioral access for a wide swath of its members.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 9, 2023
The Food and Drug Administration rejected an Alnylam Pharmaceuticals’ therapy for an increasingly prevalent heart disease, the company said Monday, citing insufficient evidence that the treatment meaningfully improved patients’ lives. Alnylam will no longer seek approval of its drug, an intravenous medicine sold as Onpattro, for people with ATTR-CM, a progressive disease that leads to heart failure if left untreated.
Fierce Healthcare
OCTOBER 9, 2023
As more patients seek tech-enabled care in the palm of their hand, providers are increasingly looking to expand their slate of virtual care offerings. | The app will make virtual care providers available around the clock for urgent issues and same-day appointments for primary care with the goal of reducing wait times for patients. All insurance types that Cedars-Sinai takes will be accepted.
Pharmacy Times
OCTOBER 9, 2023
Parents are not fully educated on the risk of meningitis infection and preventive efforts for their children.
Fierce Healthcare
OCTOBER 9, 2023
Boulder Care, a telehealth provider for substance use disorder, has met all of its performance quality measures in a value-based payment arrangement with a managed Medicaid insurer in Oregon. | The contract with Umpqua Health Alliance links reimbursement to a set of patient outcomes. Boulder agreed to put a portion of its reimbursement for medical services at risk until quality performance metrics were achieved.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
OCTOBER 9, 2023
GSK has forged a partnership with vaccine powerhouse Chongqing | GSK has forged a partnership with vaccine powerhouse Chongqing Zhifei Biological Products to distribute Shingrix in China. Zhifei will pay £2.5 billion ($3.05 billion) for exclusive rights to distribute the shingles shot in China from 2024 through 2026. The deal could be a precursor to similar arrangement between the companies for GSK’s new respiratory syncytial virus (RSV) vaccine Arexvy, the London-based drugmaker said.
Fierce Healthcare
OCTOBER 9, 2023
LAS VEGAS—Venture capital firm General Catalyst unveiled a new company Sunday designed to provide advisory services to health systems while also eyeing a big acquisition by next year. | Venture capital firm General Catalyst unveiled a new company Sunday designed to provide advisory services to health systems while also eyeing a big acquisition by next year.
STAT
OCTOBER 9, 2023
Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics: A take-under deal feels meh for biotech sector sentiment. Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.
Fierce Healthcare
OCTOBER 9, 2023
Walgreens workers are expressing their dissatisfaction at current working conditions, as reports say pharmacy workers are planning a walkout from Oct. 9 to Oct. 11. | Walgreens pharmacy workers at some locations across the country appear to be leaving work for several days. Posts on social media platforms indicate they are protesting unfair working conditions.
Fierce Pharma
OCTOBER 9, 2023
Despite an endorsement from an advisory committee, the FDA has come to a different conclusion on the benefit-risk profile for Alnylam’s Onpattro in the rare heart disease transthyretin amyloidosis | Despite an endorsement from an advisory committee, the FDA has come to a different conclusion on the benefit-risk profile for Alnylam’s Onpattro in the rare heart disease transthyretin amyloidosis cardiomyopathy (ATTR-CM).
Drug Topics
OCTOBER 9, 2023
Although vitamin D supplementation is a low-cost treatment option, the optimal dosing strategy is currently unknown.
Fierce Healthcare
OCTOBER 9, 2023
The COVID-19 pandemic underscored just how many food deserts dot the nation and how poor nutrition often lays the foundation for poor health.
Drug Store News
OCTOBER 9, 2023
HRG reviewed 34 products in the health category, 44 items in the wellness sector and 22 items in the beauty aisle to see which ones stood out as Products to Watch.
Board Vitals - Pharmacist
OCTOBER 9, 2023
Several certifying boards, including the ABIM, have rolled out a new way for practitioners to maintain their certification. In addition to the traditional 10-year maintenance of certification (MOC) exam, the 5-year Longitudinal Knowledge Assessment (LKA) is available for many specialties. Despite its open-book format, the LKA should not be taken lightly.
STAT
OCTOBER 9, 2023
LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline. There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.
Drug Store News
OCTOBER 9, 2023
Rina Hurts has been named vice president of Walmart GoLocal, arriving from Target-owned delivery company Shipt, where she served as chief business officer since April 2020.
European Pharmaceutical Review
OCTOBER 9, 2023
A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Key data from a clinical trial, published in a report in JAMA Neurology, has revealed that adding the drug XEN1101 to a patient’s current antiseizure treatments saw a 33 percent to 53 percent drop in monthly seizures, depending on dose.
Fierce Pharma
OCTOBER 9, 2023
The way we consume and engage with content is changing all the time. | How can marketers leverage AI to make sense of the masses of data they have access to? Chris Paquette, Founder and CEO of DeepIntent, explores the issues of fragmentation and outlines some of the tools designed to overcome it.
Drug Store News
OCTOBER 9, 2023
Neutrogena and Target collaborated on a new campaign that focuses on reminding consumers that when it comes to skin care, simple and science-backed is the best course of action.
Fierce Pharma
OCTOBER 9, 2023
Marketers operating in every sector are seeking ways to offer personalized, high-quality experiences to their target audiences. | How much influence will AI exert over pharma marketing? Is it a silver bullet solution to productivity and personalization challenges? Fingerpaint Group’s Paul Hagopian sits down with Fierce Pharma to discuss what has become a hotly contested topic.
European Pharmaceutical Review
OCTOBER 9, 2023
Bristol Myers Squibb ( BMS ) has agreed to acquire Mirati Therapeutics for a total of $4.8 billion. This merger deal entitles BMS to add KRAZATI (adagrasib), a best-in-class KRAS G12C inhibitor to its portfolio. The medicine is approved in the US for advanced KRAS G12C -mutated non-small cell lung cancer (NSCLC) in patients who have received at least one prior systemic treatment.
The Checkup by Singlecare
OCTOBER 9, 2023
For many, Benadryl ( diphenhydramine ) is one of those over-the-counter medications that is always kept on hand. The popular antihistamine is primarily used for allergy symptoms : It can relieve itchy eyes, itchy skin or hives, runny nose , and sneezing. It’s also indicated for cold symptoms, like congestion and sinus pressure; used as a sleep aid because of its sedative properties; and can help quell nausea and vomiting because it’s an antiemetic.
Drug Topics
OCTOBER 9, 2023
Technology may not help teens with the emotional and physical weight of managing the disease, study results show.
European Pharmaceutical Review
OCTOBER 9, 2023
MSD’s WELIREG ® (belzutifan) has been accepted for use within NHS Scotland in adults who have von Hippel-Lindau (VHL) disease. This decision by the Scottish Medicines Consortium (SMC) relates to these patients who require therapy for VHL-associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumours (pNETs), and for whom localised procedures are unsuitable or undesirable.
Pharmaceutical Technology
OCTOBER 9, 2023
GSK and Chongqing Zhifei have signed an exclusive agreement for co-promoting the former’s shingles vaccine, Shingrix, in China.
Expert insights. Personalized for you.
140 
Let's personalize your content